Recent OCX Stock Price | OCX Stock Predictions | |
$2.55 | +59.22% |
$4.06 |
Recent OCX Analyst Ratings Breakdown, Making OCX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.4 | 2.4 | 2.4 | 2.4 |
For the OCX stock predictions from the analysts covering Oncocyte Corp, we have collected all of the individual OCX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering OCX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since OCX stock predictions may vary widely, another useful metric to consider is the median OCX stock prediction, which represents the price at which half of the analysts
made OCX stock predictions that were higher and half made OCX stock predictions that were lower. This makes for a different take on the OCX stock predictions out there, as compared to average or mean.
And that median across all the individual OCX stock predictions was: $4.125 as of 2024-05-02.
The very highest of the OCX stock predictions for one year price target was $5.0, while the very lowest of the OCX stock predictions in the analyst group was
$3.0 (with a standard deviation of $0.826). Get the latest Zacks research report on OCX — FREE
Find out: OCX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
VBIV Stock Predictions
OSK Stock Predictions
DAVA Stock Predictions
CIR Stock Predictions
FTS Stock Predictions
AVY Stock Predictions
NGVT Stock Predictions
SUI Stock Predictions
PSEC Stock Predictions
|
|
Buy (2.60 out of 4) 15th percentile
(ranked lower than approx. 85% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |